Tamper seal deviation during artwork change – CAPA ineffectiveness analysis







Published on 08/01/2026

Analysis of Tamper Seal Deviation During Artwork Change: A Comprehensive Case Study

The pharmaceutical industry is governed by stringent regulations to ensure product safety, efficacy, and compliance with Good Manufacturing Practices (GMP). One area of concern is the tamper evidence on packaging, which serves as a critical component in assuring the integrity of pharmaceutical products. This case study presents a realistic scenario involving a tamper seal deviation during an artwork change, which has led to significant compliance challenges. By the end of this article, readers will learn how to detect, contain, and investigate such deviations effectively, along with implementing CAPA strategies to prevent recurrence.

If you want a complete overview with practical prevention steps, see this Packaging & Labeling Deviations.

Through the structured analysis of this case, pharma professionals will walk away with actionable insights that

enhance both their investigation protocols and overall compliance with regulatory standards set forth by organizations like the FDA, EMA, and MHRA.

Symptoms/Signals on the Floor or in the Lab

In early November 2023, Quality Assurance (QA) personnel observed discrepancies in tamper seals on the packaging line while conducting routine quality checks of newly printed artwork. The observed symptoms included:

  • Missing tamper evidence seals on 15% of randomly selected packages.
  • Improper alignment of tamper seals leading to potential gaps.
  • Variability in the seal strength, which was noted during routine testing.

These flags were quickly corroborated by findings from the Quality Control (QC) lab, where seal integrity tests indicated failure rates exceeding acceptable limits. Such evidence raised alarms regarding potential breaches in tamper-evident processes, justifying immediate action to avoid widespread impact on product quality and regulatory compliance.

Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

Understanding the potential causes for the observed tamper seal deviation is critical. A structured approach based on the 6Ms (Materials, Method, Machine, Man, Measurement, Environment) can help pinpoint the most likely sources of the issue:

Category Potential Cause
Materials Incorrect specifications of tamper-evident film used in the recent artwork change
Method Changes in the sealing process without validation or sufficient training
Machine Inadequate calibration and maintenance of sealing equipment
Man Operator oversight due to insufficient training related to the new artwork specifications
Measurement Inconsistent quality control checks not covering enough sample sizes
Environment Variable ambient conditions impacting the integrity of seal formation
Pharma Tip:  Tamper seal deviation during deviation review – regulatory reporting outcome

Immediate Containment Actions (first 60 minutes)

Upon identification of the deviation, the following containment actions were initiated immediately to mitigate the risk:

  1. Paused production on the affected packaging line to prevent further distribution of non-compliant products.
  2. Quarantined affected batches pending further investigation, documented under deviation control.
  3. Conducted an on-the-spot inventory of the packaging materials used in the recent artwork change.
  4. Informed relevant stakeholders, including packaging operations and quality assurance teams.

Timely communication and containment prevented the escalation of the issue, safeguarding product integrity and minimizing potential financial loss due to non-compliance.

Investigation Workflow (data to collect + how to interpret)

The next phase involved a systematic investigation to identify and understand the root cause. This process included:

  • Data Collection: Gathered production logs, tamper-evidence seal specifications, machine calibration records, and operator training documentation.
  • Analysis of Variability: Employed statistical methods to compare data before and after the artwork change. This helped in assessing whether the change correlatively introduced issues related to tamper seals.
  • Interviews: Conducted structured interviews with operators to identify any deviations from standard operating procedures (SOPs) and gather insights on potential human factors.

Interpreting the collected data revealed variances indicating a direct correlation between the recent artwork specifications and the observed tamper seal failures. Logistic regression analysis further confirmed that the changes made were likely contributing factors.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

Choosing the appropriate root cause analysis tool is critical in uncovering underlying issues effectively. In this case, we utilized multiple methods:

  • 5-Why Analysis: Effective for drilling down into specific failures. When we asked ‘why’ multiple times regarding the missing tamper seals, we linked it back to inadequacies in operator training and process changes.
  • Fishbone Diagram: Beneficial in visualizing potential causes and categorizing them according to the 6Ms. This collaborative tool brought different departmental insights into the investigation.
  • Fault Tree Analysis (FTA): Potentially employed if further complexity were noted. FTA could assess multiple pathways that could lead to tamper sealing failures, should our preliminary analyses indicate multiple simultaneous failure modes.
Pharma Tip:  Line clearance failure causing mix-up during packaging operations – CAPA ineffectiveness analysis

By applying these tools strategically, the investigation team was able to converge on comprehensive understanding rather than isolated findings.

CAPA Strategy (correction, corrective action, preventive action)

The Corrective and Preventive Action (CAPA) plan for this scenario was structured as follows:

  1. Correction: Immediate re-training of operators regarding the new tamper-evident seal requirements and our specific sealing methods to ensure understanding.
  2. Corrective Actions:
    • Redesign of the packaging process to include additional checks on seal integrity.
    • Adjustments made to the quality control checks to ensure comprehensive sampling across production batches.
  3. Preventive Actions:
    • Scheduled regular maintenance and validation of sealing machinery aligned with the new packaging standards.
    • Periodic audits introduced to verify adherence to updated SOPs concerning tamper seals and overall packaging integrity.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

To ensure long-term control of tamper seal integrity post-CAPA implementation, a robust control strategy was established:

  • Statistical Process Control (SPC): Implemented to monitor packaging line performance in real time, identifying deviations through trend analysis.
  • Sampling Plan: Enhanced product sampling at multiple manufacturing phases, not just finished goods, to catch any deviations early.
  • Alarm Systems: Installed to alert operators immediately for any deviations during the sealing process, ensuring real-time corrective measures.
  • Verification Protocols: Instituted routine verification of tamper-evidence seals during batch review before release.

This comprehensive monitoring framework aims to build confidence in product integrity and minimize the likelihood of future tamper seal deviations.

Related Reads

Validation / Re-qualification / Change Control impact (when needed)

Given that a significant process change occurred due to the artwork update, thorough validation and change control assessments were mandated:

  • Validation Requirements; The sealing process underwent complete re-validation to ensure adherence to new specifications and rigorous integrity testing.
  • Change Control Documentation: Comprehensive documentation of the change from the initial artwork to the current specifications, detailing the validations performed, was maintained to ensure transparency during FDA or EMA inspections.

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

In preparation for potential regulatory inspections, ensuring robust documentation is key. Evidence presented to inspectors should include:

  • Deviations Log: Clear records detailing the timeline of the tamper seal deviation and subsequent CAPA implementations.
  • Training Records: Proof of operator re-training sessions, including attendance records and revised SOP documentation.
  • Production and Packaging Logs: Detailed logs showcasing seals that passed or failed integrity tests and corresponding corrective actions taken.
  • Change Control Documentation: All relevant change control requests associated with the artwork change should be maintained, including validations and approved specifications.
Pharma Tip:  Label reconciliation failure during artwork change – regulatory reporting outcome

These records form a vital component in demonstrating compliance with GMP requirements and showing proactive quality management to inspectors from regulatory authorities.

FAQs

What is a tamper seal deviation?

A tamper seal deviation refers to any failure in the integrity of tamper-evident packaging that could allow unauthorized access to the product.

What immediate steps should be taken when a tamper seal deviation is identified?

Immediate steps include pausing production, quarantining affected products, assessing packaging materials, and notifying relevant teams.

How do you perform a root cause analysis for packaging deviations?

Utilize structured tools like the 5-Why, Fishbone diagram, and Fault Tree Analysis to systematically explore and identify underlying causes.

What elements should be included in a CAPA plan?

A CAPA plan should include correction, corrective actions, and preventive actions specifically tailored to address the root causes identified.

How can statistical process control (SPC) help in monitoring packaging processes?

SPC helps identify trends and deviations in real-time, allowing for immediate corrective actions and more robust quality control.

What documentation is required for regulatory inspection readiness?

Documentation includes deviation logs, training records, production logs, and change control documents relevant to the processes and products affected.

How often should training for operators be updated?

Training should be updated whenever there are significant changes to processes, equipment, or product specifications.

What is the purpose of change control in pharmaceutical manufacturing?

Change control ensures that any changes made to processes, materials, or systems are documented, evaluated, and managed to maintain compliance and quality.

What are the potential consequences of not addressing tamper seal deviations?

Failure to address tamper seal deviations can result in regulatory non-compliance, product recalls, financial loss, and damage to company reputation.

Why is verification important after implementing CAPA?

Verification confirms that the corrective actions taken are effective and that the issues have been resolved, ensuring continued compliance and product safety.

Where can I find regulations related to packaging and labeling deviations?

Regulations regarding packaging and labeling can be found in guidelines set by agencies such as the FDA and EMA.